Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotechnology company, announced a 1-for-10 reverse stock split of its Class A and Class ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE